Collective Mining Expands Guayabales Through ANM-Granted Mining Titles Following Public Hearings

Collective Mining Ltd. (NYSE: CNL, TSX: CNL) said Colombia’s ANM granted additional mining titles on July 10, 2026 after public hearings in Supia (May 21, 2026) and Marmato (Feb 17, 2026). The titles expand Guayabales titled land and add drill-ready targets. Company reported US$113.3M cash as of March 31, 2026 and up to 100,000m drilling planned for 2026.

Original reporting
Published Jul 13, 2026, 11:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 13, 2026, 11:35 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CNL
Bullish
medium confidence
Mentioned
$CNL
Relevance
7/10
AlphAI data visualization · based on juniorminingnetwork.com
Decision brief

The 30-second read

$CNLBullishMed
01

Why it matters

By completing titling processes in Supia and Marmato, Collective consolidates and expands its mineral title holdings, which should reduce title-related uncertainty and broaden the set of drillable targets for 2026.

02

Market read

Regulatory title grants are a concrete de-risking step for an exploration program and can support near-term drilling expectations, but the article lacks assay/resource outcomes.

03

What to watch

Execution risk remains for drilling, metallurgy, and eventual permitting for development; the article does not quantify grade, tonnage, or how much of the new ground is expected to convert to resources.

Relevance 7/10Novelty 7/10Timing: post-market July 13, 2026, following ANM title grants dated July 10, 2026

Background

Collective Mining’s Guayabales project in Caldas, Colombia has been advancing through ANM multi-stage regulatory processes tied to public hearings in local municipalities.

Company-level read

Ticker impact

$CNLBullishMedium confidence
Context

Collective Mining says ANM granted additional mining titles on July 10, 2026, expanding Guayabales titled land and adding drill-ready targets.

Expected impact

Moderately positive bias for CNL as titling reduces permitting/title risk and supports near-term drilling plans, though impact may be incremental versus a major financing or resource update.

Evidence & confidence

The article discloses a specific regulatory outcome (title grants) plus operational intent (drilling at least one new target this year) and funding/rig availability, but it does not provide resource estimates, assay results, or a quantified production/development milestone.

Market effects

Supports the broader Colombia gold exploration permitting narrative by showing ANM titling progress can unlock drill-ready ground.

May improve sentiment toward Caldas Department mining projects by highlighting successful public hearings in Supia and Marmato.

Limited direct global impact, but reinforces risk appetite for exploration developers with active permitting pipelines.

Counterpoint

Title grants do not guarantee discovery or economic viability; the market may discount the news until drilling results or resource updates confirm value.

Key entities

  • Collective Mining Ltd.

    NYSE and TSX-listed gold, silver, copper, and tungsten exploration company advancing the Guayabales project.

  • Colombian National Mining Agency (ANM)

    Granted additional mining titles to Collective following public hearings.

  • Guayabales Project

    Flagship project anchored by the Apollo system, now with expanded titled concessions and new drill-ready targets.

  • Supia and Marmato (municipalities)

    Municipalities where public hearings were held and titling processes were completed.

Related articles

$CNLHigh

Shares Jump 13% on Possible 'Hole of the Year' Gold Hit in Colombia

Collective Mining Ltd.'s shares rose 13% after reporting a high-grade gold intercept at its Apollo deposit in Colombia. Hole APC174-D4 returned 154.30 meters of 12.66 g/t gold equivalent. Analysts maintained positive ratings, citing potential for a major mining district. The company is fully funded for up to 90,000 meters of drilling in 2026. Central banks' gold purchases increased 42% year-over-year, supporting gold prices.

$CNLMedAI 8/10

Collective jumps on broad gold hit at Apollo

Collective Mining's (CNL) shares rose 13% after reporting a 154.3m gold intercept at its Apollo project in Colombia, with grades of 12.44g/t gold and 11g/t silver. The company's Executive Chairman noted the potential of the Ramp Zone. Analyst Don DeMarco maintained an outperform rating with a $32 target. Apollo's initial resource estimate includes 1.64M oz gold and 29M oz silver. The company plans further drilling and an updated resource report by early 2028.

$CNLMed

Collective slides on Apollo’s 4.1M

Collective Mining (TSX, Nasdaq: CNL) shares fell 9.4% after announcing a 4.1M oz. gold resource at its Apollo deposit in Colombia. The resource includes 1.64M oz. gold (indicated) and 2.47M oz. (inferred), with high-grade zones driving potential value. Analysts view the resource as positive, with targets of $32 and $35. The company plans further drilling and studies, aiming for construction by 2029.

$BRFHMed

Barfresh Manufacturing Recovery Drives Margins – Quarterly Update Report

Barfresh Manufacturing (BRFH) reported 3Q26 revenue of $5.8M, up 37% y/y, with gross margin rebounding to 20.9% from negative 3.2% q/q. Core margins reached 34%, and adjusted EBITDA neared breakeven. The company added 50 Ohio school districts and reactivated a major Florida district. 2026 revenue guidance was revised to $20M-$22M, with Defiance facility commissioning targeted for early to mid-2027. BRFH trades at a 75% discount to peers, offering potential rerating as growth accelerates.

$PYXSHighAI 9/10

Pyxis reports updated phase 1 data for cancer drug candidate

Pyxis Oncology (PYXS) reported updated Phase 1 data for micvotabart pelidotin, showing a 39% response rate in 33 patients with recurrent/metastatic head and neck cancer. The study reported a median progression-free survival of 6.7 months and a 94% disease control rate. Pyxis plans to initiate a Phase 3 trial in mid-2027 and expects to release more mature overall survival data in the first half of 2027.

$PYXSMedAI 8/10

Pyxis Oncology (PYXS) Reports 39% Confirmed MICVO Response Rate

Pyxis Oncology (PYXS) reported updated Phase 1 data for MICVO, showing a 39% confirmed response rate, 9.2-month median response duration, and 6.7-month median PFS in 33 patients. The company plans to start a global Phase 3 trial in mid-2027. The data is not yet confirmatory, and further results are expected in early 2027.